About

BioCurie is developing artificial intelligence (AI) - driven SaaS solutions that enable the development and manufacture of gene and cell therapies to significantly reduce time, cost and risk while at the same time improve their quality and safety through process optimization. By leveraging automation and advanced sensor data, as well as the output of upstream data sources, our SaaS solution will be fueled by big data and machine learning (ML) models that form the foundation of the continuously adaptive autonomous plant. In an industry where “the process is the product,” BioCurie will transform “the process” of development and manufacturing from an inefficient, labor-intensive and unpredictable state to a data-driven, intelligent and robust state. Our ultimate goal is to enable faster, less costly delivery of higher quality next generation Biotherapeutics that are safe and effective